AAPL   329.08 (+2.10%)
MSFT   185.64 (+1.49%)
FB   230.49 (+1.86%)
GOOGL   1,438.10 (+1.68%)
AMZN   2,467.04 (+0.26%)
CGC   16.91 (+1.68%)
BABA   219.48 (+0.66%)
MU   54.09 (+5.60%)
AMD   52.39 (-0.46%)
T   32.99 (+3.74%)
DIS   127.23 (+2.86%)
NFLX   415.54 (+0.29%)
BAC   28.53 (+6.53%)
BA   216.36 (+17.40%)
AAPL   329.08 (+2.10%)
MSFT   185.64 (+1.49%)
FB   230.49 (+1.86%)
GOOGL   1,438.10 (+1.68%)
AMZN   2,467.04 (+0.26%)
CGC   16.91 (+1.68%)
BABA   219.48 (+0.66%)
MU   54.09 (+5.60%)
AMD   52.39 (-0.46%)
T   32.99 (+3.74%)
DIS   127.23 (+2.86%)
NFLX   415.54 (+0.29%)
BAC   28.53 (+6.53%)
BA   216.36 (+17.40%)
AAPL   329.08 (+2.10%)
MSFT   185.64 (+1.49%)
FB   230.49 (+1.86%)
GOOGL   1,438.10 (+1.68%)
AMZN   2,467.04 (+0.26%)
CGC   16.91 (+1.68%)
BABA   219.48 (+0.66%)
MU   54.09 (+5.60%)
AMD   52.39 (-0.46%)
T   32.99 (+3.74%)
DIS   127.23 (+2.86%)
NFLX   415.54 (+0.29%)
BAC   28.53 (+6.53%)
BA   216.36 (+17.40%)
AAPL   329.08 (+2.10%)
MSFT   185.64 (+1.49%)
FB   230.49 (+1.86%)
GOOGL   1,438.10 (+1.68%)
AMZN   2,467.04 (+0.26%)
CGC   16.91 (+1.68%)
BABA   219.48 (+0.66%)
MU   54.09 (+5.60%)
AMD   52.39 (-0.46%)
T   32.99 (+3.74%)
DIS   127.23 (+2.86%)
NFLX   415.54 (+0.29%)
BAC   28.53 (+6.53%)
BA   216.36 (+17.40%)
Log in

NYSE:CLBCore Laboratories Stock Price, Forecast & News

$25.46
+2.49 (+10.84 %)
(As of 06/5/2020 11:40 AM ET)
Add
Compare
Today's Range
$23.10
Now: $25.46
$25.53
50-Day Range
$10.81
MA: $17.28
$21.14
52-Week Range
$6.68
Now: $25.46
$56.03
Volume18,026 shs
Average Volume790,049 shs
Market Capitalization$1.13 billion
P/E RatioN/A
Dividend Yield0.19%
Beta3.04
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry; and proprietary and joint industry studies. The Production Enhancement segment comprises services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.
Read More
Core Laboratories logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.1Community Rank: 2.1Dividend Strength: 3.3Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.30 out of 5 stars


Industry, Sector and Symbol

Industry Oil & gas field services, not elsewhere classified
Sub-IndustryN/A
CUSIPN/A
Phone31-20-420-3191

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$668.21 million
Cash Flow$2.73 per share
Book Value$4.10 per share

Profitability

Net Income$101.98 million

Miscellaneous

Employees4,300
Market Cap$1.13 billion
Next Earnings Date7/22/2020 (Estimated)
OptionableOptionable

Receive CLB News and Ratings via Email

Sign-up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter.

Core Laboratories (NYSE:CLB) Frequently Asked Questions

How has Core Laboratories' stock been impacted by COVID-19 (Coronavirus)?

Core Laboratories' stock was trading at $10.93 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CLB shares have increased by 132.9% and is now trading at $25.46. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Core Laboratories?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 1 sell rating, 11 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Core Laboratories.

When is Core Laboratories' next earnings date?

Core Laboratories is scheduled to release its next quarterly earnings announcement on Wednesday, July 22nd 2020. View our earnings forecast for Core Laboratories.

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) issued its earnings results on Wednesday, April, 22nd. The oil and gas company reported $0.31 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.33 by $0.02. The oil and gas company had revenue of $152.40 million for the quarter, compared to the consensus estimate of $151.37 million. Core Laboratories had a negative net margin of 7.21% and a positive return on equity of 46.28%. The company's quarterly revenue was down 9.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.44 earnings per share. View Core Laboratories' earnings history.

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories announced a quarterly dividend on Tuesday, April 28th. Shareholders of record on Friday, May 8th will be paid a dividend of $0.01 per share on Tuesday, May 19th. This represents a $0.04 annualized dividend and a yield of 0.16%. The ex-dividend date is Thursday, May 7th. View Core Laboratories' dividend history.

What price target have analysts set for CLB?

15 Wall Street analysts have issued 12-month target prices for Core Laboratories' shares. Their forecasts range from $7.50 to $77.00. On average, they expect Core Laboratories' share price to reach $30.93 in the next twelve months. This suggests a possible upside of 21.5% from the stock's current price. View analysts' price targets for Core Laboratories.

Has Core Laboratories been receiving favorable news coverage?

News articles about CLB stock have trended somewhat positive recently, according to InfoTrie. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Core Laboratories earned a coverage optimism score of 0.8 on InfoTrie's scale. They also gave news stories about the oil and gas company a news buzz of 3.0 out of 10, indicating that recent press coverage is unlikely to have an effect on the company's share price in the next few days. View the latest news aboutCore Laboratories.

Are investors shorting Core Laboratories?

Core Laboratories saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 6,500,000 shares, an increase of 5.3% from the April 30th total of 6,170,000 shares. Based on an average daily volume of 1,890,000 shares, the days-to-cover ratio is presently 3.4 days. Currently, 14.8% of the shares of the company are short sold. View Core Laboratories' Current Options Chain.

Who are some of Core Laboratories' key competitors?

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Chipotle Mexican Grill (CMG), Endologix (ELGX), Starbucks (SBUX), Micron Technology (MU), Gilead Sciences (GILD), Netflix (NFLX), AT&T (T) and Baidu (BIDU).

Who are Core Laboratories' key executives?

Core Laboratories' management team includes the following people:
  • Mr. David M. Demshur, CEO & Chairman of Supervisory Board (Age 64)
  • Mr. Lawrence V. Bruno, COO, Pres & Supervisory Director (Age 59)
  • Mr. Christopher Scott Hill, Sr. VP & CFO (Age 49)
  • Mr. Kevin G. Daniels, Chief Accounting Officer, Treasurer & VP (Age 55)
  • Ms. Gwendolyn Y. Schreffler M.B.A., Sr. VP of Corp. Devel. & Investor Relations

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Van ECK Associates Corp (12.38%), Massachusetts Financial Services Co. MA (7.53%), BlackRock Inc. (6.65%), Clearbridge Investments LLC (4.11%), Bank of New York Mellon Corp (3.06%) and Deutsche Bank AG (2.21%). Company insiders that own Core Laboratories stock include Gregory Barry Barnett, Jan Willem Sodderland, Kevin Daniels, Lawrence Bruno and Mark F Elvig. View institutional ownership trends for Core Laboratories.

Which major investors are selling Core Laboratories stock?

CLB stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, JPMorgan Chase & Co., Nuveen Asset Management LLC, Wells Fargo & Company MN, Principal Financial Group Inc., BlackRock Inc., Baird Financial Group Inc., and Mcdonald Capital Investors Inc. CA. View insider buying and selling activity for Core Laboratories.

Which major investors are buying Core Laboratories stock?

CLB stock was acquired by a variety of institutional investors in the last quarter, including Van ECK Associates Corp, Deutsche Bank AG, Luminus Management LLC, Bank of New York Mellon Corp, C Partners Holding GmbH, Morgan Stanley, Morgan Stanley, and Two Sigma Advisers LP. Company insiders that have bought Core Laboratories stock in the last two years include Gregory Barry Barnett, Jan Willem Sodderland, and Lawrence Bruno. View insider buying and selling activity for Core Laboratories.

How do I buy shares of Core Laboratories?

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Core Laboratories' stock price today?

One share of CLB stock can currently be purchased for approximately $25.46.

How big of a company is Core Laboratories?

Core Laboratories has a market capitalization of $1.13 billion and generates $668.21 million in revenue each year. The oil and gas company earns $101.98 million in net income (profit) each year or $1.79 on an earnings per share basis. Core Laboratories employs 4,300 workers across the globe.

What is Core Laboratories' official website?

The official website for Core Laboratories is www.corelab.com.

How can I contact Core Laboratories?

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]

This page was last updated on 6/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.